全球计划为应对耐药性结核病提供了明确的路线图。
The Global Plan provides a clear roadmap for addressing drug-resistant TB.
更令人担忧的是最近在世界范围出现的广泛耐药性结核病。
Even more alarming is the recent emergence of extensively drug-resistant TB worldwide.
《科学时报》：目前治疗耐药性结核病的主要手段有哪些？
"Science Times" : at present, the treatment of drug-resistant tuberculosis which has the primary means?
据npr新闻的杰森·博宾报道，世界卫生组织警告称，耐药性结核病将会在全球广泛蔓延。
NPR's Jason Beaubien reports that the WHO is warning that forms of drug resistant TB could spread widely around the globe.
Jakab充分认识到针对欧洲抗菌素耐药性的斗争需要持续提高警惕，否则耐药性结核病等问题将恶化。
Jakab is well aware that the struggle against antimicrobial resistance in Europe requires continuous vigilance if problems such as drug-resistant tuberculosis are not to get worse.
从那时起，莱索托把治疗耐药性结核病视为当务之急，制定了一个全国行动计划，并从一开始就寻求外部专家的帮助。
From that moment, Lesotho treated drug-resistant TB as an emergency. It created a national plan of action, and from the start sought outside experts.
此种诊断方法也可能无法严格区分潜伏性和活动性结核病，以及疾病对药物的敏感性和耐药性。
Such diagnostics also may fail to make critical distinctions between latent and active TB, and between drug sensitive and drug resistant forms of the disease.
自世界卫生组织1994年开始系统调查结核病治疗的耐药性情况以来，已注意到耐药性在持续增加。
Since the World Health Organization (WHO) began systematically surveying drug resistance to tuberculosis treatments in 1994, it has observed a continual increase in drug resistance.
在许多国家，艾滋病毒加快了结核病流行，同时多药耐药性也日益成为一大威胁。
HIV is fuelling TB epidemics in many countries and multi-drug resistance is a growing threat.
结核病，包括耐药性结核，卷土重来，被世卫组织宣布为全球卫生紧急情况。
The resurgence of tuberculosis, including its drug-resistant forms, was declared a global health emergency by WHO.
现在已有50多个国家报告出现广泛耐药结核病[2]。这是耐多药结核的一个分类，耐药性极高，结果也显著地更严重。
XDR-TB 2, a subset of MDR-TB of highly drug-resistant strains that have significantly worse outcomes, has now been reported in more than 50 countries.
现在已有50多个国家报告出现广泛耐药结核病[2]。 这是耐多药结核的一个分类，耐药性极高，结果也显著地更严重。
XDR-TB2, a subset of MDR-TB of highly drug-resistant strains that have significantly worse outcomes, has now been reported in more than 50 countries.
耐多药结核病是由对多数有效抗结核病药物（异烟肼和利福平）都具有耐药性的细菌引起的。
MDR-TB is caused by bacteria that are resistant to the most effective anti-TB drugs (isoniazid and rifampicin).
由于艾滋病和细菌耐药性的出现，结核病日益成为全球健康关注问题。
Mycobacterium tuberculosis (TB) becomes a growing international health concern because of the emergence of multi-drug-resistance of mycobacteria and AIDS.
之所以耐药性分这样的层次，是因为治疗结核病的药物也是有层次的。
The reason why such resistance at the level of treatment of tuberculosis because there are levels of the drug.
结核病的耐药性分成单耐药、多耐药、耐多药、严重耐多药这几个层次。
TB drug resistance is divided into single-drug resistance, multidrug resistance, MDR, MDR-serious levels of these.
《科学时报》：结核病的耐药性近年来制约了结核病治疗过程中的药物选择余地。
"Science Times" : the drug resistance of tuberculosis in recent years has constrained the process of TB drug treatment choice.
一般来说，如果不是被身体中已经产生耐药结核杆菌的患者直接传染，患上耐药性的结核病的可能性不大。
In general, if not already produced by the body of patients with drug-resistant Mycobacterium tuberculosis direct infection, suffering from TB drug resistance is unlikely.
一般来说，如果不是被身体中已经产生耐药结核杆菌的患者直接传染，患上耐药性的结核病的可能性不大。
In general, if not already produced by the body of patients with drug-resistant Mycobacterium tuberculosis direct infection, suffering from TB drug resistance is unlikely.
应用推荐